Genix Pharmaceuticals Corporation (GENPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.34 Thousand | - | - | - | 137.39 Thousand | 419.96 Thousand |
| Cost of Revenue | 743.44 Thousand | 564.17 Thousand | 536.61 Thousand | 361.56 Thousand | 183.08 Thousand | 327.24 Thousand |
| Gross Profit | -731.09 Thousand | -564.17 Thousand | -536.61 Thousand | -361.56 Thousand | -45.68 Thousand | 92.71 Thousand |
| Operating Expenses | 3263.00 | 1.03 Million | 1.65 Million | 715.2 Thousand | 97.64 Thousand | 117.65 Thousand |
| Selling, General and Administrative Expenses | 278.82 Thousand | 434.26 Thousand | 1.11 Million | 353.63 Thousand | 97.39 Thousand | 117.54 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -275.56 Thousand | - | - | - | - | - |
| Cost and Expenses | 893.24 Thousand | 1.03 Million | 1.65 Million | 715.2 Thousand | 280.73 Thousand | 444.9 Thousand |
| Operating Income | -880.89 Thousand | -1.03 Million | -1.65 Million | -715.66 Thousand | -143.33 Thousand | -26.12 Thousand |
| Interest Expense | 52.28 Thousand | 12.13 Thousand | 3509.00 | 3882.00 | 1779.00 | 826.00 |
| Income Tax Expense | - | 12.13 Thousand | 3509.00 | 3882.00 | 1779.00 | -158.08 Thousand |
| Earnings before Tax | -4.39 Million | -1.07 Million | -1.65 Million | -718.66 Thousand | -164.7 Thousand | -24.84 Thousand |
| Net Income | -4.39 Million | -1.07 Million | -1.65 Million | -718.66 Thousand | -164.7 Thousand | 134.07 Thousand |
| Earnings Per Share Basic | -0.07 | -0.02 | -0.03 | -0.01 | -0.00 | 0.00 |
| Earnings Per Share Diluted | -0.07 | -0.02 | -0.03 | -0.01 | -0.00 | 0.00 |
| Weighted Average Shares Outstanding | 59.22 Million | 59.22 Million | 59.22 Million | 49.95 Million | 37.51 Million | 37.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.22 Million | 59.22 Million | 59.22 Million | 49.95 Million | 37.51 Million | 37.51 Million |
| Gross Margin | -59.21 | - | - | - | -0.33 | 0.22 |
| EBIT Margin | -27.01 | - | - | - | -1.04 | -0.06 |
| Profit Margin | -356.00 | - | - | - | -1.20 | 0.32 |
| EBITDA | -333.47 Thousand | -466.89 Thousand | -1.11 Million | -317.67 Thousand | -143.08 Thousand | -23.94 Thousand |
| Earnings Before Tax Margin | -71.34 | - | - | - | -1.04 | -0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 999.00 | 2913.00 | 71.00 | - | 12.34 Thousand | 2682.00 |
| Cost of Revenue | 358.00 | 17.09 Thousand | 14.79 Thousand | 135.92 Thousand | 743.44 Thousand | 433.00 |
| Gross Profit | 641.00 | -14.18 Thousand | -14.72 Thousand | -135.92 Thousand | -731.09 Thousand | 2249.00 |
| Operating Expenses | 48.32 Thousand | 33.93 Thousand | 32.53 Thousand | 134.37 Thousand | 149.8 Thousand | 166.43 Thousand |
| Selling, General and Administrative Expenses | 40.16 Thousand | 33.93 Thousand | 32.53 Thousand | 134.37 Thousand | - | 22.98 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 8161.00 | - | - | - | - | - |
| Cost and Expenses | 48.68 Thousand | 51.02 Thousand | 47.33 Thousand | 270.3 Thousand | 893.24 Thousand | 166.87 Thousand |
| Operating Income | -47.63 Thousand | -48.12 Thousand | -47.26 Thousand | -270.3 Thousand | -880.89 Thousand | -164.15 Thousand |
| Interest Expense | 32.72 Thousand | 29.02 Thousand | 23.89 Thousand | 25.63 Thousand | 52.28 Thousand | 10.08 Thousand |
| Income Tax Expense | 32.72 Thousand | -3.00 | -3.00 | -2.00 | 379.52 Thousand | 10.08 Thousand |
| Earnings before Tax | -82.17 Thousand | -85.94 Thousand | -59.05 Thousand | -3.77 Million | -4.39 Million | -164.09 Thousand |
| Net Income | -82.17 Thousand | -85.94 Thousand | -59.05 Thousand | -3.77 Million | -4.39 Million | -164.09 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.06 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.06 | - | -0.00 |
| Weighted Average Shares Outstanding | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million | 59.22 Million |
| Gross Margin | 0.64 | -4.87 | -207.39 | - | -59.21 | 0.84 |
| EBIT Margin | -47.39 | -16.42 | -661.69 | - | - | -10.53 |
| Profit Margin | -82.25 | -29.50 | -831.80 | - | -356.00 | -61.18 |
| EBITDA | -47.34 Thousand | -47.84 Thousand | -46.98 Thousand | -134.38 Thousand | - | -28.22 Thousand |
| Earnings Before Tax Margin | -47.68 | -16.52 | -665.63 | - | -71.34 | -61.20 |
BNL
IOC
VLOWY
PHOENIXTN
002849
1I1